Transport of GM1 and GM1 inner ester across an in vitro model of the blood-brain barrier

Neuroscience Letters

Volumn 217, Issue 2-3, 1996, Pages 121-124

  Wells, John M ^a,b   Ventura, Robert F ^a,c   Eisenhauer, Patricia B ^a,b   McKenna, Daniel C ^a   Fine, Richard E ^a,b   Ullman, M David ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Blood brain barrier; Gangliosides; In vivo

Indexed keywords

GANGLIOSIDE GM1;

ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CATTLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; TIGHT JUNCTION;

EID: 0030592574     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13083-4     Document Type: Article

References (20)

1. [1] Aldinio, C., Valenti, G., Kirkschner, G., Agnati, L.F. and Toffano, G., Monosialoganglioside internal ester stimulates the dopaminergic reinnervation of the striatum after unilateral hemitransection in rat, Int. J. Dev. Neurosci., 2 (1984) 267-275.
2. +, K. + -ATPase activity defects, Diabetes Res. Clin. Pract., 12 (1991) 107-111.
3. [3] Bottenstein, J.E. and Sato, G.H., Growth of a rat neuroblastoma cell line in serum-free supplemented medium, Proc. Natl. Acad. Sci. USA, 76 (1979) 514-517.
4. [4] Dunbar, G.L., Lescaudron, L.L. and Stein, D.G., Comparison of GM1 ganglioside, AGF2, and D-amphetamine as treatments for spatial reversal and place learning deficits following lesions of the neostriatum, Behav. Brain Res., 54 (1993) 67-79.
5. [5] Emerich, D.F. and Walsh, T.J., Selective working memory impairments following intradentate injection of colchicine: attenuation of the behavioral but not the pathological effects by gangliosides GM1 and AGF2, Physiol. Behav., 45 (1989) 93-101.
6. [6] Emerich, D.F. and Walsh, T.J., Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A, Brain Res., 527 (1990) 299-307.
7. [7] Emerich, D.F. and Walsh, T.J., Ganglioside AGF2 prevents the cognitive impairments and cholinergic cell loss following intraventricular colchicine, Exp. Neurol., 112 (1991) 328-337.
8. [8] Facci, L., Leon, A. and Skaper, S.D., Hypoglycemic neurotoxicity in vitro: involvement of excitatory amino acid receptors and attenuation by monosialoganglioside GM1, Neuroscience, 37 (1990) 709-716.
9. [9] Favaron, M., Manev, H., Alho, H., Bertolino, M., Ferret, B., Guidotti, A. and Costa, E., Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex, Proc. Natl. Acad. Sci. USA, 85 (1988) 7351-7355.
10. [10] Ferrari, G., Batistatou, A. and Greene, L.A., Gangliosides rescue neuronal cells from death after trophic factor deprivation, J. Neurosci., 13 (1993) 1879-1887.
11. [11] Figliomeni, B., Bacci, B., Panozzo, C., Fogarolo, F., Triban, C. and Fiori, M.G., Experimental diabetic neuropathy: effect of ganglioside treatment on axonal transport of cytoskeletal proteins, Diabetes, 41 (1992) 866-871.
12. 2+, K + -ATPase, Drug Dev. Res., 19 (1989) 443-451.
13. [13] Leskawa, K.C., Dasgupta, S., Chien, J.-L. and Hogan, E.L., A simplified procedure for the preparation of tritiated GM1 ganglioside and other glycosphingolipids, Anal. Biochem., 140 (1984) 172-177.
14. [14] Nakamura, K., Wu, G. and Ledeen, R.W., Protection of neuro-2a cells against calcium ionophore cytotoxicity by gangliosides, J. Neurosci. Res., 31 (1992) 245-253.
15. [15] Rubin, L., Hall, D., Porter, S., Barbu, K., Cannon, C., Horner, H., Janatpour, M., Liaw, C.W., Manning, K. and Morales, J., A cell culture model of the blood-brain-barrier, J. Cell Biol., 115 (1991) 1725-1735.
16. [16] Seren, M.S., Rubini, R., Lazzaro, A., Zanoni, R., Fiori, M.G. and Leon, A., Protective effects of a monosialoganglioside derivative following transitory forebrain ischemia in rats, Stroke, 21 (1990) 1607-1612.
17. [17] Staddon, J.M., Herrenknecht, K., Smales, C. and Rubin, L.L., Evidence that tyrosine phosphorylation may increase tight junction permeability, J. Cell Sci., 108 (1995) 609-619.
18. [18] Svennerholm, L., Gangliosides - a new therapeutic agent against stroke and Alzheimer's disease, Life Sci., 55 (1994) 2125-2134.
19. [19] Takakura, Y., Audus, K. and Borchardt, R., Blood-brain-barrier: transport studies in isolated brain capillaries and in cultured brain endothelial cells, Adv. Pharmacol., 22 (1991) 137-165.
20. [20] Williams, M.A. and McCluer, R.H., The use of Sep-Pak(TM) C-18 cartridges for the isolation of gangliosides, J Neurochem, 35 (1980) 266-269.